{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:50:11Z","timestamp":1782280211718,"version":"3.54.5"},"posted":{"date-parts":[[2024,11,26]]},"group-title":"Immunology","reference-count":55,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,11,26]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as nonspecific \u201cscar reaction.\u201d This study aimed to investigate the relationship between inflammatory fibrosis and kidney disease progression in LN.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Interstitial fibrosis and tubular atrophy (IFTA) were scored in 124 LN kidney biopsies. Inflammation in areas of IFTA (i-IFTA) was graded 0-3 according to the Banff Classification of Allograft Pathology. Significant glomerular filtration rate (GFR) loss was defined as a decline of &gt;15 ml\/min at 3 years from biopsy. Immune cell phenotype was defined by serial immunohistochemistry (13-plex).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>IFTA was observed in 88\/124 (71%) biopsies, and i-IFTA was identified in 76\/88 (86%) cases. The distribution of i-IFTA grades was heterogenous across all IFTA grades. In patients with moderate-to-severe IFTA (&gt;25%), the degree of i-IFTA was associated with a higher risk of significant GFR loss: 0\/2 (0%), 1\/3 (33%), 3\/4 (75%), and 7\/9 (78%) for i-IFTA grades 0, 1, 2, and 3, respectively (p = 0.028). Multiplexed histology revealed that i-IFTA was mostly composed of CD163+ macrophages and CD4 T cells, followed by CD8 T cells and granulocytes.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>I-IFTA is frequently observed in LN and is dominated by macrophages and T cells. For patients with baseline IFTA &gt;25%, the degree of i-IFTA emerged as a predictor of GFR loss. These data support the routine scoring of i-IFTA in LN due to its prognostic implications and nominate i-IFTA as a potential therapeutic target.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>LAY SUMMARY<\/jats:title>\n                  <jats:p>Scar tissue often contains immune cells, but we still do not fully understand their role. In lupus nephritis (LN), this is typically dismissed as \u201cnonspecific inflammation\u201d. However, our study analyzed kidney biopsies from 124 people with LN and found that inflammation in scarred areas may predict future kidney function loss. Specifically, we identified a type of immune cell, CD163+ macrophages, that may contribute to scarring and kidney damage. Our findings suggest that routinely assessing inflammation in scarred areas could help predict kidney health in LN patients and highlight a possible new target for therapies to prevent kidney damage.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.11.25.625225","type":"posted-content","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:02:04Z","timestamp":1732636924000},"source":"Crossref","is-referenced-by-count":1,"title":["Inflammation in Areas of Fibrosis Precedes Loss of Kidney Function in Lupus Nephritis"],"prefix":"10.64898","author":[{"given":"Silvia","family":"Malvica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paride","family":"Fenaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9041-7023","authenticated-orcid":false,"given":"Chen-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Ida","family":"Celia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Hodgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Magder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Accelerating Medicines Partnership: RA\/SLE Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6738-4836","authenticated-orcid":false,"given":"Andrea","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024112823301313000_2024.11.25.625225v1.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.017"},{"key":"2024112823301313000_2024.11.25.625225v1.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa381"},{"key":"2024112823301313000_2024.11.25.625225v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"2024112823301313000_2024.11.25.625225v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(87)80180-4"},{"key":"2024112823301313000_2024.11.25.625225v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.108"},{"key":"2024112823301313000_2024.11.25.625225v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/jca.2920040107"},{"key":"2024112823301313000_2024.11.25.625225v1.7","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320932219"},{"key":"2024112823301313000_2024.11.25.625225v1.8","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211034234"},{"key":"2024112823301313000_2024.11.25.625225v1.9","doi-asserted-by":"crossref","unstructured":"Singh S , Sreenidhi HC . Prognostic value of modified National Institute of Health activity and chronicity scoring in determining complete renal response in newly diagnosed lupus nephritis: a retrospective single centre study. International Urology and Nephrology 2022; 54.","DOI":"10.1007\/s11255-022-03112-9"},{"key":"2024112823301313000_2024.11.25.625225v1.10","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0005512021"},{"key":"2024112823301313000_2024.11.25.625225v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.07.007"},{"key":"2024112823301313000_2024.11.25.625225v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.06.002"},{"key":"2024112823301313000_2024.11.25.625225v1.13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acr.20441","article-title":"Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring","volume":"63","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024112823301313000_2024.11.25.625225v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.02.003"},{"key":"2024112823301313000_2024.11.25.625225v1.15","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02653-y"},{"key":"2024112823301313000_2024.11.25.625225v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.11.028"},{"key":"2024112823301313000_2024.11.25.625225v1.17","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14625"},{"key":"2024112823301313000_2024.11.25.625225v1.18","first-page":"122","article-title":"Beyond ISN\/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival","volume":"3","year":"2021","journal-title":"Kidney360"},{"key":"2024112823301313000_2024.11.25.625225v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.04.031"},{"key":"2024112823301313000_2024.11.25.625225v1.20","doi-asserted-by":"crossref","unstructured":"Fava A , Buyon J , Magder L , et al. Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis. JCI Insight 2024; 9.","DOI":"10.1172\/jci.insight.172569"},{"key":"2024112823301313000_2024.11.25.625225v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2021.04.003"},{"key":"2024112823301313000_2024.11.25.625225v1.22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03275-z"},{"key":"2024112823301313000_2024.11.25.625225v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0398-x"},{"key":"2024112823301313000_2024.11.25.625225v1.24","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.09.03"},{"key":"2024112823301313000_2024.11.25.625225v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2024112823301313000_2024.11.25.625225v1.26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2024112823301313000_2024.11.25.625225v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"2024112823301313000_2024.11.25.625225v1.28","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000108969.21691.5D"},{"key":"2024112823301313000_2024.11.25.625225v1.29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.22237\/jmasm\/1020254880","article-title":"Exact level and power of permutation, bootstrap, and asymptotic tests of trend","volume":"1","year":"2002","journal-title":"Journal of Modern Applied Statistical Methods"},{"key":"2024112823301313000_2024.11.25.625225v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.048"},{"key":"2024112823301313000_2024.11.25.625225v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0"},{"key":"2024112823301313000_2024.11.25.625225v1.32","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac286"},{"key":"2024112823301313000_2024.11.25.625225v1.33","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14565"},{"key":"2024112823301313000_2024.11.25.625225v1.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03240.x"},{"key":"2024112823301313000_2024.11.25.625225v1.35","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14609"},{"key":"2024112823301313000_2024.11.25.625225v1.36","doi-asserted-by":"crossref","unstructured":"Sciascia S , Cozzi M , Barinotti A , et al. Renal Fibrosis in Lupus Nephritis. Int J Mol Sci 2022; 23.","DOI":"10.3390\/ijms232214317"},{"key":"2024112823301313000_2024.11.25.625225v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.159"},{"key":"2024112823301313000_2024.11.25.625225v1.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1300575"},{"key":"2024112823301313000_2024.11.25.625225v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.88"},{"key":"2024112823301313000_2024.11.25.625225v1.40","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313507986"},{"key":"2024112823301313000_2024.11.25.625225v1.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143961"},{"key":"2024112823301313000_2024.11.25.625225v1.42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00357.x"},{"key":"2024112823301313000_2024.11.25.625225v1.43","doi-asserted-by":"crossref","unstructured":"Huang E , Peng N , Xiao F , et al. The Roles of Immune Cells in the Pathogenesis of Fibrosis. Int J Mol Sci 2020; 21.","DOI":"10.3390\/ijms21155203"},{"key":"2024112823301313000_2024.11.25.625225v1.44","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01150113"},{"key":"2024112823301313000_2024.11.25.625225v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002046"},{"key":"2024112823301313000_2024.11.25.625225v1.46","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14609"},{"key":"2024112823301313000_2024.11.25.625225v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.183"},{"key":"2024112823301313000_2024.11.25.625225v1.48","doi-asserted-by":"publisher","DOI":"10.1159\/000342385"},{"key":"2024112823301313000_2024.11.25.625225v1.49","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12228"},{"key":"2024112823301313000_2024.11.25.625225v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0110-2"},{"key":"2024112823301313000_2024.11.25.625225v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2014.7"},{"key":"2024112823301313000_2024.11.25.625225v1.52","first-page":"228","article-title":"CD14(+) monocytes and CD163(+) macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C","volume":"20","year":"2020","journal-title":"Exp Ther Med"},{"key":"2024112823301313000_2024.11.25.625225v1.53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1114808"},{"key":"2024112823301313000_2024.11.25.625225v1.54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008146"},{"key":"2024112823301313000_2024.11.25.625225v1.55","doi-asserted-by":"publisher","DOI":"10.1002\/art.38888"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.11.25.625225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:59:26Z","timestamp":1782277166000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.11.25.625225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1101\/2024.11.25.625225","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1136\/lupus-2025-001687","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,11,26]]},"subtype":"preprint"}}